**Young Woman’s Breast Cancer Journey: From Diagnosis to Recovery**
:max_bytes(150000):strip_icc():format(jpeg)/Maddie-Squire-cancer-tout3-041426-e703a20227104b3291cc34bba1355c97.jpg)
Maddie Squire, now 26, reflects on her challenging journey after being diagnosed with stage 2 breast cancer. What began as mere dry skin turned into a life-altering experience, shedding light on the importance of advocating for one’s health.
Initially noticing flaky skin on her breast at the age of 25, Squire dismissed it as a minor irritation, attributing it to chafing. “I just put Aquaphor on it,” she recalled. As the months passed, the dryness persisted on one breast, yet she remained unconcerned. The reality shifted dramatically when she discovered a lump in April 2025, prompting her to seek medical advice.
Squire scheduled an urgent appointment at a nearby Boston hospital and was referred to its breast health centre. Without a family history of cancer, doctors initially suspected an infection or abscess. Following an ultrasound, she was given antibiotics and sent home. However, the lump did not disappear, compelling her to return for further evaluation.
On her subsequent visit, a determined radiologist advocated for a biopsy, despite initial reluctance. “I was genuinely so grateful for her because I don’t know what would have happened if she didn’t go the extra mile for me,” Squire said of the medical professional who made a critical difference in her diagnosis.
On May 23, 2025, she received the life-changing news: she had invasive ductal carcinoma (IDC), the most prevalent form of breast cancer. The diagnosis detailed that her cancer was progesterone and oestrogen-positive, HER2-negative, leading Squire to credit her medical team for their prompt care and support during a harrowing time.
Feeling fortunate for the swift journey from detection to diagnosis, which lasted only four weeks, Squire engaged various specialists to devise an appropriate treatment plan. An MRI revealed that the cancer had spread to her lymph nodes, resulting in her stage 2 diagnosis. Armed with this information, she underwent a bilateral mastectomy on June 11, during which doctors confirmed that the cancer had not spread to her other breast.
Post-surgery, Squire faced complications when one of her tissue expanders malfunctioned, requiring another surgery just weeks later. Following this setback, she began fertility preservation procedures before starting chemotherapy on July 23, 2025, where she underwent eight rounds over three months. This intensive treatment culminated in 16 rounds of radiation therapy by the end of that year.
Having finished chemotherapy just before Halloween 2025, Squire faced the next chapter of her treatment journey. In January 2026, she began hormone treatment to block oestrogen and progesterone production, essential to prevent any residual cancer cells from growing.
Squire also participated in a clinical research study involving a drug called ribociclib, originally developed for advanced stages of breast cancer. “I’m very excited to participate in that just because my life is proof that cancer research works,” she stated, emphasising her commitment to contributing to the advancement of cancer treatment.
The experience of battling a life-threatening illness proved daunting, as Squire described the transition from leading a normal life to grappling with a daunting diagnosis. While navigating the complexities of her condition, she relied on guidance from a family friend who had previously faced breast cancer, implementing a checklist to mark her progress during treatment.
“It made me feel more productive,” she mentioned, highlighting the psychological benefits of tracking her journey through each chemotherapy session and other procedures. Her ability to compartmentalise the ordeal helped manage the overwhelming nature of her new reality.
Looking ahead, Squire is upbeat about the future as she prepares for her reconstruction surgery – a significant milestone almost a year following her mastectomy. “It does feel closer to ending every day in a really positive way,” she expressed, demonstrating resilience in the face of adversity.
Squire’s story serves as a poignant reminder of the importance of vigilance regarding health and the value of self-advocacy in medical settings. Her experiences not only illustrate the challenges of a cancer journey but also highlight the advances in medical research and the personal strength needed to navigate such trials.